![Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - België Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - België](https://www.ypsomed.com/files/media/02_Images/09_Press_Releases/Ajovy_Pen_CMYK_DE_ohneSchatten_low.png)
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - België
Thomas Thoma – Head Managed Access Programs- Clinical Trials, Global Health Tendering and UEUM (Director) – Mepha / Teva Switzerland | LinkedIn
![Breaking News: Der Startschuss für eine BioTech-CBD-Erfolgsstory durch Schweizer Ex-Nestlé-Spitzenmanager! Breaking News: Der Startschuss für eine BioTech-CBD-Erfolgsstory durch Schweizer Ex-Nestlé-Spitzenmanager!](https://i2.wp.com/bullvestorbb.com/wp-content/uploads/2020/08/Scanlan.jpg?resize=737%2C417&ssl=1)
Breaking News: Der Startschuss für eine BioTech-CBD-Erfolgsstory durch Schweizer Ex-Nestlé-Spitzenmanager!
![Most Active Swiss Domestic Bonds 21.05.2021 – Credit Suisse Guernsey, Aryzta, MSC Cruises, Swisscom, Basilea Pharma – Financial Markets Blog – by Zuberbühler Associates AG Most Active Swiss Domestic Bonds 21.05.2021 – Credit Suisse Guernsey, Aryzta, MSC Cruises, Swisscom, Basilea Pharma – Financial Markets Blog – by Zuberbühler Associates AG](https://zuberbuehlerassociates.files.wordpress.com/2021/05/domestic-bonds-2021-05-22_3.png?w=387)